Federal 43.5% research tax rebate payable in advance on trial cost expenditure is I suspect behind the return to the original trial design parameters ...- the company would need to confirm this as I could be wide of the mark but is seems a reasonable explanation
red or black as always
Ann: Avecho to present at NWR Virtual Healthcare Conference, page-13
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 43869108 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 44263580 | 22 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable